Logo image of BENF

BENEFICIENT - CLASS A (BENF) Stock Fundamental Analysis

NASDAQ:BENF - Nasdaq - US08178Q3092 - Common Stock - Currency: USD

0.611  +0 (+0.16%)

Premarket: 0.6206 +0.01 (+1.57%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BENF. BENF was compared to 223 industry peers in the Capital Markets industry. BENF has a bad profitability rating. Also its financial health evaluation is rather negative. BENF has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BENF had negative earnings in the past year.
In the past year BENF has reported a negative cash flow from operations.
In the past 5 years BENF always reported negative net income.
BENF had a negative operating cash flow in each of the past 5 years.
BENF Yearly Net Income VS EBIT VS OCF VS FCFBENF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -500M -1B -1.5B -2B

1.2 Ratios

BENF has a Return On Assets of -148.54%. This is amonst the worse of the industry: BENF underperforms 99.54% of its industry peers.
Industry RankSector Rank
ROA -148.54%
ROE N/A
ROIC N/A
ROA(3y)-192.54%
ROA(5y)-115.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BENF Yearly ROA, ROE, ROICBENF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

BENF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BENF Yearly Profit, Operating, Gross MarginsBENF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, BENF has less shares outstanding
BENF has a worse debt/assets ratio than last year.
BENF Yearly Shares OutstandingBENF Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
BENF Yearly Total Debt VS Total AssetsBENF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of -8.99, we must say that BENF is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.99, BENF is doing worse than 94.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.99
ROIC/WACCN/A
WACCN/A
BENF Yearly LT Debt VS Equity VS FCFBENF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

A Current Ratio of 0.04 indicates that BENF may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.04, BENF is doing worse than 96.79% of the companies in the same industry.
A Quick Ratio of 0.04 indicates that BENF may have some problems paying its short term obligations.
BENF has a Quick ratio of 0.04. This is amonst the worse of the industry: BENF underperforms 96.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
BENF Yearly Current Assets VS Current LiabilitesBENF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.56% over the past year.
Looking at the last year, BENF shows a very strong growth in Revenue. The Revenue has grown by 54.14%.
EPS 1Y (TTM)69.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.03%
Revenue 1Y (TTM)54.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%120.02%

3.2 Future

BENF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.85% yearly.
BENF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.81% yearly.
EPS Next Y99.69%
EPS Next 2Y41.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year119.67%
Revenue Next 2Y41.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BENF Yearly Revenue VS EstimatesBENF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 50M -50M 100M -100M
BENF Yearly EPS VS EstimatesBENF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BENF. In the last year negative earnings were reported.
BENF is valuated cheaply with a Price/Forward Earnings ratio of 0.07.
Based on the Price/Forward Earnings ratio, BENF is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BENF to the average of the S&P500 Index (95.03), we can say BENF is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.07
BENF Price Earnings VS Forward Price EarningsBENF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BENF Per share dataBENF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150

4.3 Compensation for Growth

BENF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BENF's earnings are expected to grow with 41.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.85%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BENF!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BENEFICIENT - CLASS A

NASDAQ:BENF (2/5/2025, 8:00:01 PM)

Premarket: 0.6206 +0.01 (+1.57%)

0.611

+0 (+0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners30.7%
Inst Owner Change0%
Ins Owners13.18%
Ins Owner Change-44.8%
Market Cap3.10M
AnalystsN/A
Price Target5.1 (734.7%)
Short Float %3.13%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-133.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)73.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.07
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-177.64
EYN/A
EPS(NY)8.16
Fwd EY1335.52%
FCF(TTM)-10.21
FCFYN/A
OCF(TTM)-9.87
OCFYN/A
SpS-6.81
BVpS-32.54
TBVpS-35.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -148.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-192.54%
ROA(5y)-115.94%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover-0.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 65.35%
Cap/Sales -5.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -8.99
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)101.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.03%
EPS Next Y99.69%
EPS Next 2Y41.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)54.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%120.02%
Revenue Next Year119.67%
Revenue Next 2Y41.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y55.67%
OCF growth 3YN/A
OCF growth 5YN/A